VANGUARD GROUP INC 13D and 13G filings for Black Diamond Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 3:33 pm Sale | 2021-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX | VANGUARD GROUP INC | 1,014,791 2.800% | -831,171 (-45.03%) | Filing |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX | VANGUARD GROUP INC | 1,845,962 5.130% | 1,845,962 (New Position) | Filing |